Press release
Deadline on September 28th coming up in the Lawsuit that was filed for Investors in Ardelyx, Inc. (NASDAQ: ARDX)
A Deadline is coming up on September 28, 2021 in the lawsuit for certain investors in Ardelyx, Inc. (NASDAQ: ARDX).
Investors who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX) have certain options and there are strict and short deadlines running. Deadline: September 28, 2021. NASDAQ: ARDX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Ardelyx, Inc. (NASDAQ: ARDX) common shares between August 6, 2020 and July 19, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 6, 2020 and July 19, 2021, Ardelyx and the other named defendants made materially false and misleading statements regarding tenapanor and the likelihood that it would be approved by the FDA, which led investors to suffer significant losses.
Those who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on September 28th coming up in the Lawsuit that was filed for Investors in Ardelyx, Inc. (NASDAQ: ARDX) here
News-ID: 2386773 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Ardelyx
Short Bowel Syndrome Market Deep Research 2025-2032 | Ardelyx, Inc., Emmaus Life …
The Global Short Bowel Syndrome Market is expected to grow at CAGR 21.6% from 2025 to 2032.
The Latest comprehensive Research Report on the Short Bowel Syndrome Market 2025-2032, Outlook is performed by determining industry drivers, dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. The Short Bowel Syndrome Market report has…
Hyperkalemia Treatment Market Moving in the Right Direction: AstraZeneca, Ardely …
The latest study released on the Global Hyperkalemia Treatment Market by HTF MI Research evaluates market size, trend, and forecast to 2030. The Hyperkalemia Treatment market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players…
Hyperphosphatemia Market to Witness Upsurge in Growth During the Forecast Period …
DelveInsight's "Hyperphosphatemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hyperphosphatemia, historical and forecasted epidemiology as well as the Hyperphosphatemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Hyperphosphatemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hyperphosphatemia Market Forecast
https://www.delveinsight.com/sample-request/hyperphosphatemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Hyperphosphatemia…
Investigation for Investors in NASDAQ: ARDX shares over possible Wrongdoing at A …
An investigation was announced for current long-term investors in shares of Ardelyx, Inc. (NASDAQ: ARDX) was announced over potential breaches of fiduciary duties by certain officers and directors at Ardelyx, Inc.
Investors who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Ardelyx, Inc. directors breached their fiduciary…
Ardelyx, Inc. (NASDAQ: ARDX) Long Term Investor Notice: Lawsuit filed against Di …
An investor in shares of Ardelyx, Inc. (NASDAQ: ARDX) filed a lawsuit against certain directors of Ardelyx, Inc over alleged breaches of fiduciary duties.
Investors who are current long term investors in Ardelyx, Inc. (NASDAQ: ARDX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges that certain directors engaged in insider trading and made false and misleading statements about…
Lawsuit filed for Investors in shares of Ardelyx, Inc. (NASDAQ: ARDX)
An investor, who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX), filed a lawsuit over alleged violations of Federal Securities Laws by Ardelyx, Inc.
Investors who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX) have certain options and for certain investors are short and strict deadlines running. Deadline: September 28, 2021. NASDAQ: ARDX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Fremont, CA based Ardelyx, Inc., a biopharmaceutical…
